We discuss the chemistry of cannabis with Markus Roggen, PhD. In his various roles and positions, Dr. Roggen oversaw multiple teams that are focused on the whole processing flow of cannabis production, from harvest and drying, through processing and extraction, all the way to the formulation and quality control/analytics. In addition to cannabinoids, Dr. Roggen's company, Complex Biotech Discovery Ventures (CBDV), is also investigating psilocybin.



Topics discussed include: 



The number of compounds that have been identified in the cannabis plant, and whether there are more to be foundThe complexity of cannabis compared to other plants and herbsThe challenges with the entourage effect. Could there be an invisible compound that is responsible for certain therapeutic effects?How different storage conditions and extraction techniques will yield different chemical compounds Why the term "whole-plant extract" is a misnomer The potential uses for psilocybin, and how it compares to cannabis



Thanks to Our Sponsor: CANN



Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.



Additional Resources



Complex Biotech Discovery Ventures (CBDV) website Collaborative Research into Cannabis Delivery Techniques and Fundamental Product Makeup | CannMed 2019 presentation